1026066-42-1

Basic information

• Product Name: (S)-2-[((S)-2-{(S)-2-[Benzyloxycarbonyl-((R)-2-tert-butoxycarbonylamino-3-tritylsulfanyl-propyl)-amino]-3-methyl-butyryl}-1,2,3,4-tetrahydro-isoquinoline-3-carbonyl)-amino]-4-methanesulfonyl-butyric acid
• CAS NO: 1026066-42-1
• Molecular Weight: 1005.27
• Mol File: 1026066-42-1.mol

Chemical Properties

• CAS DataBase Reference: (S)-2-[((S)-2-{(S)-2-[Benzyloxycarbonyl-((R)-2-tert-butoxycarbonylamino-3-tritylsulfanyl-propyl)-amino]-3-methyl-butyryl}-1,2,3,4-tetrahydro-isoquinoline-3-carbonyl)-amino]-4-methanesulfonyl-butyric acid(CAS DataBase Reference)
• NIST Chemistry Reference: (S)-2-[((S)-2-{(S)-2-[Benzyloxycarbonyl-((R)-2-tert-butoxycarbonylamino-3-tritylsulfanyl-propyl)-amino]-3-methyl-butyryl}-1,2,3,4-tetrahydro-isoquinoline-3-carbonyl)-amino]-4-methanesulfonyl-butyric acid(1026066-42-1)
• EPA Substance Registry System: (S)-2-[((S)-2-{(S)-2-[Benzyloxycarbonyl-((R)-2-tert-butoxycarbonylamino-3-tritylsulfanyl-propyl)-amino]-3-methyl-butyryl}-1,2,3,4-tetrahydro-isoquinoline-3-carbonyl)-amino]-4-methanesulfonyl-butyric acid(1026066-42-1)

Safety Data

• Hazardous Substances Data: 1026066-42-1(Hazardous Substances Data)

Upstream product

• 166169-43-3 (R*)-N-amino>-3-<(triphenylmethyl)thio>propyl>-N-(benzyloxycarbonyl)-L-valyl>-1,2,3,4-tetrahydroisoquinoline-2-carboxylic acid methyl ester 
• 166169-44-4 (R*)-N-amino>-3-<(triphenylmethyl)thio>propyl>-N-(benzyloxycarbonyl)-L-valyl>-1,2,3,4-tetrahydroisoquinoline-2-carboxylic acid 
• 166169-41-1 (R*)-N-<<2-<<(1,1-dimethylethoxy)carbonyl>amino>-3-<(triphenylmethyl)thio>propyl>carbonyl>-N-(benzyloxycarbonyl)-L-valine methyl ester 
• 166169-42-2 (R*)-N-<<2-<<(1,1-dimethylethoxy)carbonyl>amino>-3-<(triphenylmethyl)thio>propyl>carbonyl>-N-(benzyloxycarbonyl)-L-valine 
• 166169-40-0 N-<<2-<<(1,1-dimethylethoxy)carbonyl>amino>-3-<(triphenylmethyl)thio>propyl>carbonyl>-L-valine methyl ester 
• 149910-63-4 N-α-(tert-butoxycarbonyl)-S-(triphenylmethyl)-L-cysteinal 
• 6306-52-1 L-valine methylester hydrochloride 

Relevant articles and documents

Development of highly potent inhibitors of Ras farnesyltransferase possessing cellular and in vivo activity

Analogs of CVFM (a known nonsubstrate farnesyltransferase (FT) inhibitor derived from a CA2A2X sequence where C is cysteine, A is an aliphatic residue, and X is any residue) were prepared where phenylalanine was replaced by (Z)-dehyd